Skip NavigationSkip to Content
Return Return to Search Results

Subunit recombinant vaccine protects against monkeypox

  1. Author:
    Heraud, J. M.
    Edghill-Smith, Y.
    Ayala, V.
    Kalisz, I.
    Parrino, J.
    Kalyanaraman, V. S.
    Manischewitz, J.
    King, L. R.
    Hryniewicz, A.
    Trindade, C. J.
    Hassett, M.
    Tsai, W. P.
    Venzon, D.
    Nalca, A.
    Vaccari, M.
    Silvera, P.
    Bray, M.
    Graham, B. S.
    Golding, H.
    Hooper, J. W.
    Franchini, G.

  2. Author Address

    NCI, Anim Models & Retroviral Vaccines Sect, Bethesda, MD 20892 USA. So Res Inst, Frederick, MD 21701 USA. Adv BioSci Labs, Kensington, MD 20895 USA. NIAID, Vaccine Res Ctr, Bethesda, MD 20892 USA. US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA. Med Univ Bialystok, Dept Gen & Expt Pathol, Bialystok, Poland. NCI, Biostat & Data Management Sect, Bethesda, MD 20892 USA. USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA. NIAID, Biodef Clin Res Branch, Bethesda, MD 20892 USA.;Franchini, G, NCI, Anim Models & Retroviral Vaccines Sect, Bldg 41,Room D-804, Bethesda, MD 20892 USA.;franchig@mail.nih.gov
    1. Year: 2006
    2. Date: Aug
  2. Journal: Journal of Immunology
    1. 177
    2. 4
    3. Pages: 2552-2564
  4. Type of Article: Article
  5. ISSN: 0022-1767
  1. Abstract:

    The smallpox vaccine Dryvax, a live vaccinia virus (VACV), protects against smallpox and monkeypox, but is contraindicated in immunocompromised individuals. Because Abs to VACV mediate protection, a live virus vaccine could be substituted by a safe subunit protein-based vaccine able to induce a protective Ab response. We immunized rhesus macaques with plasmid DNA encoding the monkeypox orthologs of the VACV L1R, A27L, A33R, and B5R proteins by the intradermal and i.m. routes, either alone or in combination with the equivalent recombinant proteins produced in Escherichia coli. Animals that received only DNA failed to produce high titer Abs, developed innumerable skin lesions after challenge, and died in a manner similar to placebo controls. By contrast, the animals vaccinated with proteins developed moderate to severe disease (20-155 skin lesions) but survived. Importantly, those immunized with DNA and boosted with proteins had mild disease with 15 or fewer lesions that resolved within days. DNA/protein immunization elicited Th responses and binding Ab titers to all four proteins that correlated negatively with the total lesion number. The sera of the immunized macaques recognized a limited number of linear B cell epitopes that are highly conserved among orthopoxviruses. Their identification may guide future efforts to develop simpler, safer, and more effective vaccines for monkeypox and smallpox.

    See More

  1. Keywords:

External Sources

  1. View record in Web of Science®
  2. WOS: 000239745300064

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel